Amylyx Pharmaceuticals, Inc. Common Stock AMLX
$29.49
-2.16%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-152,092,000
- Net Margin
- —
- Return on Equity
- -63.59%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 15.74
- Price / Sales
- —
Over the trailing twelve months, Amylyx Pharmaceuticals, Inc. Common Stock generated revenue of — and net income of $-152,092,000.
Key Stats
- Last Close
- $29.49
- Market Cap
- $3.76 billion
- 52-Week Range
- $8.47 – $41.14
- Average Volume
- 3.03 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.